Articles



INOVIO Pharmaceuticals

INOVIO’s INO-3107 Shows Powerful Potential for Treating Recurrent Respiratory Papillomatosis

PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) has unveiled promising peer-reviewed results from its Phase 1/2 clinical trial for INO-3107, a cutting-edge DNA medicine designed to treat recurrent respiratory papillomatosis (RRP). …

INOVIO’s INO-3107 Shows Powerful Potential for Treating Recurrent Respiratory Papillomatosis Read More
Real Estate News

High Mortgage Rates Upend the Market—How Buyers Can Finally Take Control This Year!

SEATTLE, WA — Persistently high mortgage rates are reshaping the U.S. housing market, creating opportunities for buyers as sellers adapt to a slower-paced market, according to Zillow’s recent analysis. With mortgage …

High Mortgage Rates Upend the Market—How Buyers Can Finally Take Control This Year! Read More